Cryoablation Devices Market, By Device Type, by Application, by End User, and by Regions - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Cryotherapy and radiofrequency ablation (RFA) are the two clinically viable ablation systems that are widely used in liver cancer management. Cryotherapy is a treatment that uses extreme cold for denaturing the diseased tissues in the human body. The procedure is often carried out multiple times till the affected tissue is totally destroyed. The technique yields high effectiveness for treatment of various tumors such as that in the bones, kidneys, breasts, lungs, and liver, and can also be used to treat certain skin conditions. The probe is guided using MRI and ultrasound, which locates the exact position of the affected tissue that provides the targeted therapy.

Market Dynamics

Adoption of cryoablation procedures is growing as cryoablation is a minimally invasive procedure that decreases the chances of major surgery and thus helps with rapid recovery of the patient. Percutaneous procedure used for the therapy involves use of a thin, needle size probe that is inserted in the body through a small incision. In 2017, according to Radcliffe Cardiology, cryoablation process for treating cardiac arrhythmia is now being considered as a safe and effective alternative to radio frequency ablation therapy.

Key features of the study:

• This report provides in-depth analysis of the global cryoablation devices market and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022 - 2028), considering 2021 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global cryoablation devices market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
• Key companies covered as a part of this study include Medtronic Inc., Galil Medical Inc., AtriCure, Inc., IceCure Medical, CryoConcepts LP, Brymill Cryogenic Systems, CooperSurgical, and Sanarus Technologies
• Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding future product launches, technology up-gradation, market expansion, and marketing tactics
• The global cryoablation devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cryoablation devices market

Detailed Segmentation:

• Global Cryoablation Devices Market, By Device Type:
  • Systems
  • Probes
• Global Cryoablation Devices Market, By Application:
  • Prostate Cancer
  • Renal Cancer
  • Liver Cancer
  • Breast Cancer
  • Others
• Global Cryoablation Devices Market, By End User:
  • Hospitals
  • Ambulatory Surgical Centers
  • Surgical Clinics
• Global Cryoablation Devices Market, By Region:
  • North America
    • By Device Type:
    • Systems
    • Probes
    • By Application:
    • Prostate Cancer
    • Renal Cancer
    • Liver Cancer
    • Breast Cancer
    • Others
    • By End User:
    • Hospitals
    • Ambulatory Surgical Centers
    • Surgical Clinics
    • By Country:
    • U.S.
    • Canada
  • Latin America
    • By Device Type:
    • Systems
    • Probes
    • By Application:
    • Prostate Cancer
    • Renal Cancer
    • Liver Cancer
    • Breast Cancer
    • Others
    • By End User:
    • Hospitals
    • Ambulatory Surgical Centers
    • Surgical Clinics
    • By Country:
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • By Device Type:
    • Systems
    • Probes
    • By Application:
    • Prostate Cancer
    • Renal Cancer
    • Liver Cancer
    • Breast Cancer
    • Others
    • By End User:
    • Hospitals
    • Ambulatory Surgical Centers
    • Surgical Clinics
    • By Country:
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • By Device Type:
    • Systems
    • Probes
    • By Application:
    • Prostate Cancer
    • Renal Cancer
    • Liver Cancer
    • Breast Cancer
    • Others
    • By End User:
    • Hospitals
    • Ambulatory Surgical Centers
    • Surgical Clinics
    • By Country:
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • By Device Type:
    • Systems
    • Probes
    • By Application:
    • Prostate Cancer
    • Renal Cancer
    • Liver Cancer
    • Breast Cancer
    • Others
    • By End User:
    • Hospitals
    • Ambulatory Surgical Centers
    • Surgical Clinics
    • By Country:
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • By Device Type:
    • Systems
    • Probes
    • By Application:
    • Prostate Cancer
    • Renal Cancer
    • Liver Cancer
    • Breast Cancer
    • Others
    • By End User:
    • Hospitals
    • Ambulatory Surgical Centers
    • Surgical Clinics
    • By Country:
    • South Africa
    • Central Africa
    • North Africa
• Company Profiles
  • Medtronic Inc.*
    • Company Overview
    • Material Portfolio
    • Financial Performance
    • Key Highlights
    • Market Strategies
  • Galil Medical Inc.
  • AtriCure, Inc.
  • IceCure Medical
  • CryoConcepts LP
  • Brymill Cryogenic Systems
  • Cooper Surgical
  • Sanarus Technologies

"*" marked represents similar segmentation in other categories in the respective section.